RecruitingPhase 3NCT06016842
Rare condition
Primary biliary cholangitis
55
studies recruiting now
as of 7 Sept 2026
327
studies registered in total
as of 7 Sept 2026
30
countries with a recruiting site
as of 7 Sept 2026
29 Apr 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT07387549
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
RecruitingNCT06447168
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
RecruitingNCT04685200
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
RecruitingNCT07556913
Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 55 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Primary biliary cholangitis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Primary biliary cholangitis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (IL12RB1, SPIB, IL12A, IRF5, TNPO3, MMEL1).
Treatments being studied
4 approved treatments and 33 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Taurursodiol (Taurursodiol component of relyvrio)Approved: Ursodiol (Actigall)Approved: Norucholic AcidApproved: Obeticholic Acid (Ocaliva)
Phase 3Bezafibrate (Bezagen xl)
Phase 3Taurolithocholic Acid
Phase 3Budesonide (Aircort)
Phase 3Tiomolibdate Ion
Phase 3Magnesium
Phase 3Saroglitazar
Phase 3Colchicine (Colchicine component of col-probenecid)
Phase 3Elafibranor (Iqirvo)
+ 25 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).